ERNA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ernexa Therapeutics Inc (ERNA) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. The company shows significant financial underperformance, no positive trading trends, and lacks any strong positive catalysts. Additionally, technical indicators suggest a bearish trend, and there are no proprietary trading signals to support a buy decision.
The MACD is slightly positive but contracting, indicating weakening momentum. The RSI is neutral at 39.547, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level (0.197), with resistance at 0.208 and support at 0.187. Overall, the technical indicators suggest a bearish trend.
NULL identified. No recent news or significant trading trends from hedge funds or insiders.
The lack of any positive news or trading trends further weakens the stock's outlook.
In Q4 2025, revenue dropped to $0 (-100% YoY), net income fell to -$1.51 million (-73.82% YoY), and EPS declined to -0.18 (-92.04% YoY). Gross margin also dropped to 0 (-100% YoY), indicating severe financial distress.
No data available on analyst ratings or price target changes.
